0001666071-21-000142.txt : 20210624
0001666071-21-000142.hdr.sgml : 20210624
20210624171552
ACCESSION NUMBER: 0001666071-21-000142
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210623
FILED AS OF DATE: 20210624
DATE AS OF CHANGE: 20210624
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Grimes Scott D.
CENTRAL INDEX KEY: 0001617486
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38386
FILM NUMBER: 211043741
MAIL ADDRESS:
STREET 1: CARDLYTICS, INC.
STREET 2: 675 PONCE DE LEON AVENUE NE, SUITE 6000
CITY: ATLANTA
STATE: GA
ZIP: 30308
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cardlytics, Inc.
CENTRAL INDEX KEY: 0001666071
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROGRAMMING, DATA PROCESSING, ETC. [7370]
IRS NUMBER: 263039436
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 675 PONCE DE LEON AVENUE, NE
STREET 2: SUITE 6000
CITY: ATLANTA
STATE: GA
ZIP: 30308
BUSINESS PHONE: 888-798-5802
MAIL ADDRESS:
STREET 1: 675 PONCE DE LEON AVENUE, NE
STREET 2: SUITE 6000
CITY: ATLANTA
STATE: GA
ZIP: 30308
4
1
wf-form4_162456930298925.xml
FORM 4
X0306
4
2021-06-23
0
0001666071
Cardlytics, Inc.
CDLX
0001617486
Grimes Scott D.
C/O CARDLYTICS, INC.
675 PONCE DE LEON AVENUE NE, SUITE 6000
ATLANTA
GA
30308
1
0
0
0
Common Stock
2021-06-23
4
S
0
100
123.64
D
242574
D
Common Stock
2021-06-23
4
S
0
1014
125.35
D
241560
D
Common Stock
2021-06-23
4
S
0
601
126.31
D
240959
D
Common Stock
2021-06-23
4
S
0
285
127.01
D
240674
D
Common Stock
77112
I
See Footnote
These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 12, 2020.
The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $124.84 to $125.83, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), and (4) to this Form 4.
The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $125.87 to $126.71, inclusive.
The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $126.90 to $127.08, inclusive.
The reportable securities are held by the 2013 Scott Grimes GRAT UAD.
/s/ Kirk Somers, Attorney-in-Fact
2021-06-24